​

Phibro Animal Health (PAHC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PAHC Stock Forecast

Phibro Animal Health (PAHC) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $34.00, with a high of $34.00 and a low of $34.00. This represents a -18.43% decline from the last price of $41.68.

$10 $17 $24 $31 $38 $45 High: $34 Avg: $34 Low: $34 Last Closed Price: $41.68

PAHC Stock Rating

Phibro Animal Health stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (46.15%), 3 Hold (23.08%), 4 Sell (30.77%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 4 3 6 Strong Sell Sell Hold Buy Strong Buy

PAHC Price Target Upside V Benchmarks

TypeNameUpside
StockPhibro Animal Health-18.43%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks18.82%

Price Target Trends

1M3M12M
# Anlaysts-13
Avg Price Target-$34.00$26.67
Last Closing Price$41.68$41.68$41.68
Upside/Downside--18.43%-36.01%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 251-2-14
Sep, 251-2-14
Aug, 251-2-14
Jul, 25--3-14
Jun, 25--2-24
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 28, 2025Morgan Stanley$34.00$38.46-11.60%-18.43%
Jun 25, 2025Morgan Stanley$26.00$24.755.05%-37.62%
Apr 15, 2025Erin WrightMorgan Stanley$20.00$16.8118.98%-52.02%
Dec 21, 2022Roth Capital$18.00$12.7541.18%-56.81%
Sep 16, 2022Barclays$17.00$14.2918.96%-59.21%
Aug 26, 2022Morgan Stanley$21.00$16.0630.76%-49.62%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 04, 2025Exane BNP ParibasNeutralNeutralhold
May 10, 2024BarclaysUnderweightUnderweighthold
Dec 21, 2022Roth CapitalBuyinitialise
Sep 16, 2022BarclaysUnderweightUnderweighthold
Aug 26, 2022Morgan StanleyEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28
Reported$1.34$1.21$0.81$0.06$1.19---
Avg Forecast$1.26$1.34$1.22$1.12$1.54$1.87$2.10$2.63
High Forecast$1.49$1.57$1.34$1.13$1.76$1.98$2.30$2.88
Low Forecast$1.00$1.06$1.12$1.03$1.40$1.62$1.93$2.42
Surprise %6.35%-9.70%-33.61%-94.64%-22.73%---

Revenue Forecast

$650M $820M $990M $1B $1B $2B Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28
Reported$833.35M$942.30M$977.89M$1.02B$1.30B---
Avg Forecast$827.38M$938.41M$979.13M$1.00B$1.18B$1.35B$1.36B$1.30B
High Forecast$939.31M$1.07B$1.05B$1.08B$1.36B$1.46B$1.42B$1.39B
Low Forecast$692.82M$785.79M$919.75M$941.90M$1.08B$1.21B$1.29B$1.22B
Surprise %0.72%0.41%-0.13%1.49%9.71%---

Net Income Forecast

$0 $30M $60M $90M $120M $150M Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28
Reported$54.38M$49.17M$32.61M$2.42M$48.26M---
Avg Forecast$38.48M$51.86M$49.43M$17.41M$64.03M$73.06M$85.71M$106.58M
High Forecast$46.18M$62.24M$54.15M$20.89M$71.36M$80.34M$93.12M$116.76M
Low Forecast$30.79M$41.49M$45.53M$13.92M$56.70M$65.77M$78.30M$98.17M
Surprise %41.33%-5.18%-34.03%-86.12%-24.62%---

PAHC Forecast FAQ

Is Phibro Animal Health stock a buy?

Phibro Animal Health stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 3 Hold, 4 Sell, and 0 Strong Sell, reflecting a consensus that Phibro Animal Health is a favorable investment for most analysts.

What is Phibro Animal Health's price target?

Phibro Animal Health's price target, set by 13 Wall Street analysts, averages $34 over the next 12 months. The price target range spans from $34 at the low end to $34 at the high end, suggesting a potential -18.43% change from the previous closing price of $41.68.

How does Phibro Animal Health stock forecast compare to its benchmarks?

Phibro Animal Health's stock forecast shows a -18.43% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (18.82%).

What is the breakdown of analyst ratings for Phibro Animal Health over the past three months?

  • October 2025: 25.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 25.00% Strong Sell.
  • September 2025: 25.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 25.00% Strong Sell.
  • August 2025: 25.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 25.00% Strong Sell.

What is Phibro Animal Health’s EPS forecast?

Phibro Animal Health's average annual EPS forecast for its fiscal year ending in June 2026 is $1.87, marking a 57.14% increase from the reported $1.19 in 2025. Estimates for the following years are $2.1 in 2027, and $2.63 in 2028.

What is Phibro Animal Health’s revenue forecast?

Phibro Animal Health's average annual revenue forecast for its fiscal year ending in June 2026 is $1.35B, reflecting a 3.79% increase from the reported $1.3B in 2025. The forecast for 2027 is $1.36B, and $1.3B for 2028.

What is Phibro Animal Health’s net income forecast?

Phibro Animal Health's net income forecast for the fiscal year ending in June 2026 stands at $73.06M, representing an 51.37% increase from the reported $48.26M in 2025. Projections indicate $85.71M in 2027, and $106.58M in 2028.